🔎 Trials Near Me

Avaleht › Ateroskleroos › Indiana

Ateroskleroos kliinilised uuringud osariigis Indiana

8 uuringut haiguse Ateroskleroos jaoks otsivad osalejaid osariigis Indiana.

Linnad osariigis Indiana

Ametlik uuringutekst (inglise keeles)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07783802

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • IU Health Bloomington, Bloomington
  • Indiana University Health Methodist Hospital, Indianapolis
  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. sept 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Cardiovascular Research of Northwest Indiana LLC, Munster
  • Velocity Clinical Research - Valparaiso, Valparaiso
VärbamineFaas 3
Vanused 45–99 · Kõik sood · Uuendatud 22. sept 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • NANI Research, Fort Wayne
  • Nephrology Physician's LLC, Mishawaka
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 21. sept 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Evansville
  • Research Site, Evansville
  • Research Site, Indianapolis
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. aug 2026 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

  • American Health Network Research Dept, Muncie
  • American Health Network Research Dept, Muncie
VärbamineFaas 3
Vanused 18–80 · Kõik sood · Uuendatud 7. aug 2026 · NCT06813911

Pharmacogenomic Informed Statin Prescribing

  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Värbamine
Vanused 40–75 · Kõik sood · Uuendatud 13. apr 2026 · NCT06568601

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.